TICKERNOMICS Sign up
Last Update: 2023-12-23 06:04:25
TREVENA INC ( TRVN ) https://www.trevena.com
0.69USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-57.67%
TRVN
SPY
30.72%
-98.88%
TRVN
SPY
112.82%
-92.90%
TRVN
SPY
201.04%
TRVN
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
9.64
10.98
0.10
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.33
3.48
2.71
-489.07
0.00
-0.32
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-4903.89
2.78
-1008.50
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
13.0922
-68.31
-61.27
2.23
Other Earnings and Cash Flow Stats:
TREVENA INC ( TRVN ) Net Income TTM ($MM) is -36.19
TREVENA INC ( TRVN ) Operating Income TTM ($MM) is -44.05
TREVENA INC ( TRVN ) Owners' Earnings Annual ($MM) is 0.00
TREVENA INC ( TRVN ) Current Price to Owners' Earnings ratio is 0.00
TREVENA INC ( TRVN ) EBITDA TTM ($MM) is -43.52
TREVENA INC ( TRVN ) EBITDA Margin is -1008.50%
Capital Allocation:
TREVENA INC ( TRVN ) has paid 0.00 dividends per share and bought back -7.135286 million shares in the past 12 months
TREVENA INC ( TRVN ) has increased its debt by 15.17 million USD in the last 12 months
Capital Structure:
TREVENA INC ( TRVN ) Interest-bearing Debt ($MM) as of last quarter is 36
TREVENA INC ( TRVN ) Annual Working Capital Investments ($MM) are 4
TREVENA INC ( TRVN ) Book Value ($MM) as of last quarter is 3
TREVENA INC ( TRVN ) Debt/Capital as of last quarter is 1022%
Other Balance Sheet Stats:
TREVENA INC ( TRVN ) has 34 million in cash on hand as of last quarter
TREVENA INC ( TRVN ) has 6 million of liabilities due within 12 months, and long term debt 29 as of last quarter
TREVENA INC ( TRVN ) has 13 common shares outstanding as of last quarter
TREVENA INC ( TRVN ) has 0 million USD of preferred stock value
Academic Scores:
TREVENA INC ( TRVN ) Altman Z-Score is -19.15 as of last quarter
TREVENA INC ( TRVN ) Piotroski Score is 4.00 as of last quarter
Corporate Governance:
TREVENA INC ( TRVN ) largest shareholder is HRT FINANCIAL LLC owning 19082 shares at 0.01 ($MM) value
Barry Shin(an insider) Sold 1271 shares of TREVENA INC ( TRVN ) for the amount of $13027.75 on 2022-06-28
1.09% of TREVENA INC ( TRVN ) is held by insiders, and 8.81% is held by institutions
TREVENA INC ( TRVN ) went public on 2014-01-31
Other TREVENA INC ( TRVN ) financial metrics:
FCF:-41.15
Unlevered Free Cash Flow:0.00
EPS:-2.27
Operating Margin:-4903.89
Gross Profit Margin:2.78
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-893.77
Beta:2.23
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About TREVENA INC ( TRVN ) :
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.